BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 18570056)

  • 1. Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study.
    Kalinchenko S; Vishnevskiy EL; Koval AN; Mskhalaya GJ; Saad F
    Aging Male; 2008 Jun; 11(2):57-61. PubMed ID: 18570056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lower urinary tract symptoms and its potential relation with late-onset hypogonadism.
    Pradidarcheep W
    Aging Male; 2008 Jun; 11(2):51-5. PubMed ID: 18570055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of testosterone therapy on lower urinary tract symptoms/bladder and sexual functions in men with symptomatic late-onset hypogonadism.
    Karazindiyanoğlu S; Cayan S
    Aging Male; 2008 Sep; 11(3):146-9. PubMed ID: 18821291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction.
    Mulhall JP; Valenzuela R; Aviv N; Parker M
    Urology; 2004 Feb; 63(2):348-52; discussion 352-3. PubMed ID: 14972487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone replacement therapy by testosterone ointment relieves lower urinary tract symptoms in late onset hypogonadism patients.
    Amano T; Imao T; Takemae K; Iwamoto T; Nakanome M
    Aging Male; 2010 Dec; 13(4):242-6. PubMed ID: 20795793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men.
    Haider A; Gooren LJ; Padungtod P; Saad F
    Andrologia; 2009 Feb; 41(1):7-13. PubMed ID: 19143723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rationale, design and methods of the ESPRIT study: Energy, Sexual desire and body PropoRtions wIth AndroGel, Testosterone 1% gel therapy, in hypogonadal men.
    Behre HM; Heinemann L; Morales A; Pexman-Fieth C
    Aging Male; 2008 Jun; 11(2):101-6. PubMed ID: 18570063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging.
    Cavallini G; Caracciolo S; Vitali G; Modenini F; Biagiotti G
    Urology; 2004 Apr; 63(4):641-6. PubMed ID: 15072869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of testosterone gel followed by parenteral testosterone undecanoate on sexual dysfunction and on features of the metabolic syndrome.
    Saad F; Gooren L; Haider A; Yassin A
    Andrologia; 2008 Feb; 40(1):44-8. PubMed ID: 18211301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testosterone supplementation: what and how to give.
    Jockenhövel F
    Aging Male; 2003 Sep; 6(3):200-6. PubMed ID: 14628500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study.
    Roehrborn CG; McVary KT; Elion-Mboussa A; Viktrup L
    J Urol; 2008 Oct; 180(4):1228-34. PubMed ID: 18722631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between lower urinary tract symptoms and erectile dysfunction in men presenting for prostate cancer screening.
    Reggio E; de Bessa J; Junqueira RG; Timm O; Sette MJ; Sansana V; Gomes CM
    Int J Impot Res; 2007; 19(5):492-5. PubMed ID: 17554395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sildenafil citrate improves erectile function and lower urinary tract symptoms independent of baseline body mass index or LUTS severity.
    McVary KT; Siegel RL; Carlsson M
    Urology; 2008 Sep; 72(3):575-9. PubMed ID: 18597830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of 5-year treatment with testosterone undecanoate on lower urinary tract symptoms in obese men with hypogonadism and metabolic syndrome.
    Francomano D; Ilacqua A; Bruzziches R; Lenzi A; Aversa A
    Urology; 2014 Jan; 83(1):167-73. PubMed ID: 24139347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transdermal testosterone gel increases serum testosterone levels in hypogonadal men in Taiwan with improvements in sexual function.
    Chiang HS; Hwang TI; Hsui YS; Lin YC; Chen HE; Chen GC; Liao CH
    Int J Impot Res; 2007; 19(4):411-7. PubMed ID: 17538639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate.
    Saad F; Gooren LJ; Haider A; Yassin A
    J Androl; 2008; 29(1):102-5. PubMed ID: 17916569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral testosterone replacement in Korean patients with PADAM.
    Hong JH; Ahn TY
    Aging Male; 2002 Mar; 5(1):52-6. PubMed ID: 12040976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogonadism is associated with overt depression symptoms in men with erectile dysfunction.
    Makhlouf AA; Mohamed MA; Seftel AD; Niederberger C
    Int J Impot Res; 2008; 20(2):157-61. PubMed ID: 17703222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome.
    Demir O; Akgul K; Akar Z; Cakmak O; Ozdemir I; Bolukbasi A; Can E; Gumus BH
    Aging Male; 2009 Mar; 12(1):29-34. PubMed ID: 19326294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
    Coward RM; Simhan J; Carson CC
    BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.